News
17h
Medpage Today on MSNNovel Vaccine Shows Promise in Pancreatic Cancer
An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Cover - Video on MSN22h
New Pancreatic Cancer Vaccine Shows Promise in Early Trial, Offering Fresh Hope for Patients
A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival ...
A new experimental pancreatic cancer vaccine may help stop the disease from coming back. it targets common gene mutations found in about 90% of pancreatic cancers.
Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...
16h
GlobalData on MSNElicio’s peptide cancer vaccine shows survival benefit in Phase I trial
The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...
In this week’s InnovationRx newsletter, we look at longevity drugs for dogs, programmable mRNA for fighting cancer, AI models ...
It ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so.” Mark Twain’s quip ...
When HHS Secretary Robert Kennedy Jr. terminated nearly $500 million in mRNA research last week, he didn’t just cripple our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results